• Stem Cell Transplants Work for Many Myeloma Patients Who Fail to Respond to First-line Therapies, Study Finds
  • Systemic Gaps in Cancer Care Are Detrimental to Patient Outcomes, Survey Finds
  • Kyprolis-Dexamethasone Combo Allows Relapsed Myeloma Patients to Live Longer, Amgen Says
  • Kyprolis Regimen Reduces Risk of Death in Relapsed Multiple Myeloma Patients, Studies Show
  • KD025 Shows Promise for Chronic Graft-Versus-Host Disease, a Common Complication of Stem Cell Transplants
  • Multiple Myeloma Research Foundation Is Planning $15 Million Immunotherapy Initiative
  • FDA Suspends Keytruda Combination Trials for Myeloma After Patient Deaths
  • FDA Approves Lab Test to Help Detect Myeloma
  • Bristol-Myers Squibb Issues Four-year Follow-up Findings for Empliciti Triple Combo Therapy
  • Potential Use of Ninlaro as Maintenance Therapy in Multiple Myeloma Shown in Phase 1/2 Trials
  • 76-year-old Don Wright Has New Goal After Completing 100 Marathons with Myeloma
  • FDA Will Review Amgen’s Request to Expand Use of Xgeva for Multiple Myeloma